Important safety information Certain GLP-1 therapies such as semaglutide (the active ingredient in Ozempic, Rybelsus, and Wegovy), liraglutide (the active ingredient in Saxenda and Victoza), and tirzepatide (the active ingredient in Mounjaro and Zepbound) may increase the likelihood of developing thyroid gland tumors, including MTC, a type of thyroid cancer
While bioavailability questions remain incompletely answered, the formulation selection demonstrates attention to scientific considerations rather than arbitrary product development
UpdatedSeptember 23 rd 2010
This timeline allows the body to adapt to improved NAD+ availability and mitochondrial function
(Advent Health) presented on the unique needs of the heterogenous population of older people living with T1D
Our team of experts will form a plan that will supercharge your health, making our clinic your ultimate blue zone destination